Musashino Red Cross Hospital
Musashino, Japan
General hospital in Musashino
1 Chome-26-1 Kyonancho, Musashino, Tokyo 180-8610
About Musashino Red Cross Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Musashino Red Cross Hospital
During the past decade, Musashino Red Cross Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 12 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 8 clinical trials were completed. i.e. 266.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis
2008-03-17
2009-04-15
Completed
65
Bulking Agents for the Treatment of Stress Urinary Incontinence in Females
2008-04-01
2013-05-01
Completed
345
Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH)
2008-03-01
2009-08-01
Completed
528
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
2010-06-01
Active, not recruiting
2,527
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
2010-11-01
2013-12-01
Terminated
84
DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma
2011-06-01
2015-07-01
Terminated
142
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
2012-06-12
2023-06-30
Active, not recruiting
1,194
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
2012-08-08
2027-07-19
Active, not recruiting
129
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Musashino Red Cross Hospital" #1 sponsor was "Gilead Sciences" with 5 trials, followed by "Hoffmann-La Roche" with 3 trials
sponsored, "Pfizer" with 3 trials sponsored, "Janssen Sciences Ireland UC" with 2 trials sponsored and "Associations for Establishment of Evidence in Interventions"
with 2 trials sponsored. Other sponsors include 3 different institutions and
companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Musashino Red Cross Hospital"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Japan Clinical Research Support Unit(J-CRSU)" with 1 trials as a collaborator and "University Hospital Medical Information Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Musashino Red Cross Hospital
According to Clinical.Site data, the most researched conditions in "Musashino Red Cross Hospital" are
"Carcinoma, Hepatocellular" (4 trials), "Advanced Hepatocellular Carcinoma" (2 trials), "HBV" (2 trials), "Hepatitis B, Chronic" (2 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Musashino Red Cross Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Musashino Red Cross Hospital
Most popular intervention types in "Musashino Red Cross Hospital" are "Drug" (18 trials), "Device" (2 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Atezolizumab" (3 trials), "JNJ-56136379" (3 trials), "Sorafenib" (3 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Musashino Red Cross Hospital
The vast majority of trials in "Musashino Red Cross Hospital" are
22 trials for "All" genders.
Clinical Trials Status at Musashino Red Cross Hospital
Currently, there are NaN active trials in "Musashino Red Cross Hospital".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Musashino Red Cross Hospital,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Musashino Red Cross Hospital, 1 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".